Financials
- Market Capitalization 26.39 M
- Employee 19
- Founded 2015
- CEO N/A
- Website www.abvcpharma.com
- Headquarter Nevada, United States
- FIGI BBG000Q844Z2
- Industry Biotecnologia
Ricavi totali
Utile netto
Utile base per azione (EPS base)
Debito totale
Liquidità libera
Disponibilità liquide e mezzi equivalenti
Rapporto prezzo/utili
-5.46
Rapporto prezzo/fatturato
—
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 4396 | RNAZ TransCode Therapeutics, Inc. - Common Stock | 1.63 USD | -12.37% | -7.91% | -1.21% | -82.86% | 27.60 M USD | ||
| 4405 | MCRB Seres Therapeutics, Inc. - Common Stock | 2.68 USD | -1.11% | -6.94% | -46.40% | -67.44% | 26.64 M USD | ||
| 4415 | BYSI BeyondSpring, Inc. - Ordinary Shares | 0.62 USD | +1.64% | -18.42% | -18.42% | -63.53% | 25.49 M USD | ||
| 4419 | EVAX Evaxion A/S - American Depositary Share | 3.00 USD | -2.28% | -7.41% | -5.36% | -9.64% | 25.02 M USD |